Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 28.70 | (22.70) | (19.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 47.64 | (18.95) | (15.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Local Digest | 10-May-2009 | Washington Post |
| Novavax Moves Closer to Licensing Bird Flu Vaccine | 27-Aug-2008 | Washington Post |
| Business Briefing | 09-Aug-2008 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 1.27 |
| Change Today | $ 0.02 |
| % Change | 1.60 % |
| 52 Week High | $2.41 |
| 52 Week Low | $1.16 |
| Volume | 358,656 |
| Shares Issued | 122.15m |
| Market Cap | $155.13m |
| Beta | 1.63 |
| RiskGrade | 244 |
| Strong Buy | 5 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |

| Time | Volume / Share Price |
| 16:00 | 28,164 @ $1.27 |
| 15:59 | 930 @ $1.28 |
| 15:59 | 101 @ $1.28 |
| 15:59 | 100 @ $1.28 |
| 15:59 | 100 @ $1.28 |
You are here: research